Clinical Trial Update: A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 multicenter open-label extension trial of Phenoptin in individuals with phenylketonuria and elevated phenylalani…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• Phenoptin

Snippet

Sponsor: BioMarin Pharmaceutical | Conditions: Phenylketonurias | Phase 3 | Status: COMPLETED